Psoriatic arthropathy in patients with previous neoplasia: a case series of four patients treated with secukinumab and literature review

CONCLUSIONS: In conclusion, our case series, consisting of four PsA patients with concurrent neoplasia treated with secukinumab, showed no evidence of cancer progression and represents the first case of PsA described in the literature treated during active oncological disease, lending support to the safety of secukinumab for the treatment of patients with PsA and concomitant neoplasia.PMID:38639525 | DOI:10.26355/eurrev_202404_35919
Source: Pharmacological Reviews - Category: Drugs & Pharmacology Authors: Source Type: research